000 | 01925 a2200541 4500 | ||
---|---|---|---|
005 | 20250514191412.0 | ||
264 | 0 | _c20040701 | |
008 | 200407s 0 0 eng d | ||
022 | _a0039-6060 | ||
024 | 7 |
_a10.1016/j.surg.2003.11.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBlack, Dalliah | |
245 | 0 | 0 |
_aTNF alpha-induced hepatocyte apoptosis is associated with alterations of the cell cycle and decreased stem loop binding protein. _h[electronic resource] |
260 |
_bSurgery _cJun 2004 |
||
300 |
_a619-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xphysiology |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aDNA _xmetabolism |
650 | 0 | 4 |
_aHepatocytes _xcytology |
650 | 0 | 4 |
_aI-kappa B Proteins _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide Synthase _xgenetics |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
650 | 0 | 4 |
_aProteins _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
650 | 0 | 4 | _aRNA-Binding Proteins |
650 | 0 | 4 | _aS Phase |
650 | 0 | 4 | _aTNF Receptor-Associated Factor 2 |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
650 | 0 | 4 |
_amRNA Cleavage and Polyadenylation Factors _xmetabolism |
700 | 1 | _aBird, Mark A | |
700 | 1 | _aHayden, Melissa | |
700 | 1 | _aSchrum, Laura W | |
700 | 1 | _aLange, Patricia | |
700 | 1 | _aSamson, Charles | |
700 | 1 | _aHatano, Etsuro | |
700 | 1 | _aRippe, Richard A | |
700 | 1 | _aBrenner, David A | |
700 | 1 | _aBehrns, Kevin E | |
773 | 0 |
_tSurgery _gvol. 135 _gno. 6 _gp. 619-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.surg.2003.11.004 _zAvailable from publisher's website |
999 |
_c14886862 _d14886862 |